Early Thrombectomy Reduces Intubation in Intermediate-Risk Pulmonary Embolism

Optimizing Intervention Timing in Intermediate-Risk Pulmonary Embolism

Management strategies for intermediate-risk pulmonary embolism have shifted toward catheter-based interventions as clinicians seek to mitigate the risks of right ventricular failure and circulatory collapse [1]. Recent meta-analyses indicate that mechanical thrombectomy (a procedure using specialized catheters to physically remove blood clots from the pulmonary arteries) may offer superior 30-day survival and shorter intensive care stays compared to anticoagulation alone [2, 3]. While randomized trials have confirmed that these devices effectively reduce the right ventricle-to-left ventricle ratio (a measure of heart strain where a ratio ≥1.0 indicates significant dysfunction), the optimal window for performing these procedures remains poorly defined [4, 5]. Current evidence suggests that mechanical thrombectomy is associated with low rates of major bleeding and rapid hemodynamic improvement, yet the clinical impact of procedural delay is a subject of ongoing debate [6]. A new multicenter study now examines whether the interval between diagnosis and intervention influences mortality and respiratory outcomes in this specific patient population.

Comparing Early and Delayed Mechanical Thrombectomy

The clinical decision to proceed with catheter-directed therapy often hinges on the balance between immediate stabilization and the logistical constraints of specialized intervention. To clarify this timing, researchers conducted a multicenter, retrospective cohort study across five large academic hospitals, evaluating 290 patients presenting with intermediate-risk pulmonary embolism who underwent mechanical thrombectomy. The cohort was stratified into two distinct groups based on the interval between diagnosis and the start of the procedure: early intervention, defined as mechanical thrombectomy performed less than 12 hours after diagnosis, and delayed intervention, defined as the procedure occurring 12 hours or more after diagnosis. Among the participants, early intervention was performed in 179 patients (61.7%), while delayed intervention was performed in 111 patients (38.3%). The primary outcome was in-hospital mortality, providing a direct look at whether the urgency of the procedure translates to a survival benefit. Initial findings showed that unadjusted mortality rates did not differ significantly between the groups, with 7.3% (13/179) in the early intervention group compared to 10.8% (12/111) in the delayed intervention group (p = 0.39). Even after adjusting for the Pulmonary Embolism Severity Index and Composite Pulmonary Embolism Shock scores, the timing of the intervention did not significantly influence mortality (odds ratio, 1.80; 95% CI, 0.82 to 3.95; p = 0.14). These results suggest that for the stable intermediate-risk patient, a 12 hour delay may not necessarily increase the risk of death, though secondary clinical benefits remain a critical consideration.

Mortality Outcomes and Risk Adjustment

Rigorous statistical controls are essential when evaluating retrospective data to ensure that the perceived safety of a delay is not merely a reflection of lower baseline risk in the delayed group. To address this, the researchers utilized generalized estimated equations (a statistical method used to estimate the parameters of a generalized linear model while accounting for potential correlations between outcomes in different hospital settings). This approach allowed the team to compare the odds of in-hospital mortality while adjusting for pulmonary embolism severity and other potential confounders. Specifically, the model incorporated the Pulmonary Embolism Severity Index (a validated clinical tool used to predict the 30 day mortality risk based on age, comorbidities, and vital signs) and the Composite Pulmonary Embolism Shock scores. Despite these adjustments, the unadjusted mortality rate of 7.3% (13/179) in the early group and 10.8% (12/111) in the delayed group remained statistically comparable. The final adjusted odds ratio of 1.80 (95% CI, 0.82 to 3.95; p = 0.14) confirms that timing alone was not a primary driver of mortality in this cohort. For the practicing physician, this indicates that while the procedure is effective, the 12 hour mark does not represent a hard physiological threshold for survival, allowing for more nuanced clinical judgment in the timing of resource mobilization.

Hemodynamic Recovery and Respiratory Support

While survival rates remained stable across both groups, the physiological benefits of rapid clot removal were markedly more pronounced in those treated early. Patients in the early intervention group experienced a reduction in pulmonary artery systolic pressure of -25.8% (17.0), whereas those in the delayed intervention group saw a reduction of -18.9% (17.1). This difference in the relief of right ventricular afterload (the resistance the heart must pump against to move blood through the lungs) was statistically significant (p = 0.020). Similar trends were noted in the mean pulmonary artery pressure, which represents the average pressure within the pulmonary arterial system throughout the cardiac cycle. The early intervention group achieved a reduction in mean pulmonary artery pressure of -26.8% (17.7), compared to a reduction of -20.2% (19.7) in the delayed intervention group (p = 0.016). Beyond these hemodynamic markers, the timing of the procedure was a significant predictor of respiratory failure. The intubation rate in the early intervention group was 8.9% (16/179), while the intubation rate in the delayed intervention group was 18% (20/111). This statistically significant difference (p = 0.028) indicates that patients who underwent mechanical thrombectomy later were more than twice as likely to require invasive mechanical ventilation. For the clinician, these findings suggest that while delaying the procedure may not increase the risk of in-hospital death, it is associated with a higher likelihood of respiratory failure and less efficient resolution of pulmonary hypertension. Consequently, early mechanical intervention may serve as a vital strategy to accelerate hemodynamic stabilization and avoid the morbidity associated with invasive airway management.

References

1. Zoumpourlis P, Mangeshkar S, Chi K, et al. Catheter-Based Therapies in Acute Pulmonary Embolism-Mortality and Safety Outcomes: A Systematic Review and Meta-Analysis.. Journal of clinical medicine. 2025. doi:10.3390/jcm14124167

2. Chan JM, Betancourt VVV, Almeida JM, et al. Mechanical Thrombectomy Versus Anticoagulation in Intermediate-Risk Pulmonary Embolism: A Systematic Review and Meta-Analysis.. Cardiovascular and interventional radiology. 2026. doi:10.1007/s00270-026-04423-5

3. Husseiny YM, Ramadan S, El-Helbawy A, et al. Mechanical Thrombectomy Versus Conventional Anticoagulants Alone in Treatment of Pulmonary Embolism: A Systematic Review and Meta-Analysis.. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2026. doi:10.1002/ccd.70412

4. Lookstein RA, Konstantinides SV, Weinberg I, et al. Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes From the STORM-PE Trial.. Circulation. 2026. doi:10.1161/CIRCULATIONAHA.125.077232

5. Jaber WA, Gonsalves CF, Stortecky S, et al. Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in the Management of Intermediate-Risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled Trial.. Circulation. 2025. doi:10.1161/CIRCULATIONAHA.124.072364

6. Schuster GR, Maciel RC, Merighi MC, et al. Catheter-Directed Mechanical Thrombectomy without Thrombolysis for Intermediate-to-High-Risk Acute Pulmonary Embolism: A Systematic Review and Meta-Analysis.. Cardiovascular and interventional radiology. 2026. doi:10.1007/s00270-026-04416-4